Carlumab (Anti-CCL2 / MCP1) | Immunology & Inflammation related

Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.

Click to purchase the isotype control of Carlumab (Anti-CCL2 / MCP1)

Purity & Quality Control

Batch: A257301 Purity: 99% Protein concentration: 3.8mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description	Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.

Product Details

CAS No.	915404-94-3
Molecular Weight	145.5 kDa
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field